lercanidipine has been researched along with Chronic Kidney Diseases in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (25.00) | 24.3611 |
| 2020's | 3 (75.00) | 2.80 |
| Authors | Studies |
|---|---|
| Franczyk, B; Fularski, P; Hajdys, J; Leszto, K; Majchrowicz, G; Młynarska, E; Rysz, J; Stabrawa, M | 1 |
| Arazzi, M; Colucci, M; Esposito, C; Esposito, V; Pasquinucci, E; Sileno, G | 1 |
| Balthazar Nardotto, GH; Barbosa Coelho, E; Dantas, M; Hanauer Schaab, E; Lanchote, VL; Marques Pereira, MP; Paiva, CE | 1 |
| Minushkina, LO | 1 |
2 review(s) available for lercanidipine and Chronic Kidney Diseases
| Article | Year |
|---|---|
New Insights into the Nephroprotective Potential of Lercanidipine.
Topics: Antihypertensive Agents; Blood Pressure; Calcium Channel Blockers; Dihydropyridines; Humans; Hypertension; Renal Insufficiency, Chronic | 2023 |
[Treatment of arteril hypertension in patients with chronic kidney disease: a fixed combination of lercanidipine and enalapril].
Topics: Antihypertensive Agents; Blood Pressure; Dihydropyridines; Drug Combinations; Enalapril; Glomerular Filtration Rate; Humans; Hypertension; Renal Insufficiency, Chronic; Treatment Outcome | 2013 |
1 trial(s) available for lercanidipine and Chronic Kidney Diseases
| Article | Year |
|---|---|
Effect of Lercanidipine on the Pharmacokinetics-Pharmacodynamics of Carvedilol Enantiomers in Patients With Chronic Kidney Disease.
Topics: Administration, Oral; Adult; Antihypertensive Agents; Carvedilol; Case-Control Studies; Cross-Over Studies; Cytochrome P-450 Enzyme System; Dihydropyridines; Drug Interactions; Female; Glomerular Filtration Rate; Heart Rate; Humans; Hypertension; Male; Middle Aged; Renal Insufficiency, Chronic; Stereoisomerism | 2020 |
1 other study(ies) available for lercanidipine and Chronic Kidney Diseases
| Article | Year |
|---|---|
Don't judge the book by its cover….
Topics: Chylous Ascites; Dihydropyridines; Humans; Peritoneal Dialysis, Continuous Ambulatory; Peritonitis; Renal Insufficiency, Chronic | 2021 |